Stockreport

Inocras and Summit Pharmaceuticals International Corporation Announce Collaboration Aim to Transform Clinical Genomics in Japan [Yahoo! Finance]

SUMITOMO CORP S/ADR  (SSUMY) 
NASDAQ:AMEX Investor Relations: sumitomocorp.co.jp/en/ir
PDF Suh) ("Inocras") and Summit Pharmaceuticals International Corporation (Head Office: Hitotsubashi, Chiyoda-ku, Tokyo, President & CEO: Katsuya Okuyama) ("SPI") signed an [Read more]